LWMG LLC’s Pfizer PFE Stock Holding History

LWMG LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-8,211	Closed	-$236K	–	91
2023 Q4	$236K	Sell	8,211 -1,979	-19%	-$59.8K	0.06%	82
2023 Q3	$338K	Sell	10,190 -192	-2%	-$6.79K	0.09%	63
2023 Q2	$381K	Sell	10,382 -349	-3%	-$13.6K	0.11%	63
2023 Q1	$438K	Sell	10,731 -1,667	-13%	-$72K	0.14%	54
2022 Q4	$635K	Buy	+12,398	New	+$594K	0.23%	47

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

LWMG LLC's PFE Position: Q1 2024 in Review

LWMG LLC sold out of Pfizer (PFE) in Q1 2024, closing a stake of 8,211 shares — an estimated $236K sold.

LWMG LLC first reported a position in PFE in Q4 2022 and held it in 5 quarters. The position peaked at $635K in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

LWMG LLC reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
LWMG LLC sold 8,211 Pfizer shares in Q1 2024, an estimated $236K.
LWMG LLC first reported a position in Pfizer in Q4 2022 and held it in 5 quarters.
LWMG LLC's Pfizer position peaked at $635K in Q4 2022.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on LWMG LLC's 13F filing for Q1 2024, filed 2 May 2024.